Vsee Health, Inc. (VSEEW)
VSEEW is quoted over the counter, not listed on an exchange. Vsee Health, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Profile
| Field | Value |
|---|---|
| Ticker | VSEEW, quoted over the counter |
| SEC CIK | 0001864531 |
| SEC industry code | Services-Health Services |
| Business address | Boca Raton, FL |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of one year from the issuance of these financial statements." | 10-Q 2026-08-14 |
| Cash and burn | $454K cash; operating cash flow -$1.6M a quarter. | Report 2026-06-30 |
| Shares outstanding | 56,679,813 (2026-08-12); 16,422,690 a year earlier; 4,183,123 three years earlier. | Cover page 2026-08-12 |
| Reverse splits, 3 years | 1; latest on 2026-09-23 | Source 2026-09-23 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | 1 (8-K item 3.01) | 8-K 2026-08-04 |
| Auditor | WWC, P.C., San Mateo, California, United States; changed auditors 1 time in 24 months | 8-K 4.01 2025-10-14 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $1.6M | -$1.7M | -$1.2M | $454K | $2.0M | $12.6M | 10-Q 2026-08-14 |
| Q1 2026 2026-03-31 | $3.2M | -$2.6M | -$2.5M | $1.3M | $2.2M | $12.1M | 10-Q 2026-05-15 |
| Q4 2025 2025-12-31 | $3.9M | -$7.9M | -$1.9M | $5.1M | $2.4M | $12.3M | 10-K 2026-03-31 |
| Q3 2025 2025-09-30 | $4.0M | -$290K | -$755K | $473K | $3.4M | $12.1M | 10-Q 2025-11-14 |
| Q2 2025 2025-06-30 | $1.1M | -$2.6M | -$325K | $292K | $3.0M | $11.5M | 10-Q 2026-08-14 |
| Q1 2025 2025-03-31 | $3.3M | -$4.0M | -$440K | $410K | $2.6M | $12.1M | 10-Q 2026-05-15 |
| Q4 2024 2024-12-31 | $3.7M | -$3.2M | -$3.0M | $326K | $1.9M | $10.4M | 10-K 2026-03-31 |
| Q3 2024 2024-09-30 | $3.4M | -$53.9M | -$221K | $2.3M | $1.9M | $8.2M | 10-Q 2025-11-14 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1 | 2026-10-01 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K | 2026-09-30 |
| Latest proxy | DEF 14A | 2026-07-20 |
Source: SEC EDGAR submissions feed, 288 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier